1/11
Looks like no tags are added yet.
what is Kymriah, and what type of therapy does it use
Kymriah (tisagenlecleucel) is a DNA-based CAR-T cell therapy delivered using a lentiviral vector
It is used to treat B-cell acute lymphoblastic leukaemia (ALL) and B-cell non-Hodgkin lymphoma
what is Yescarta, and what type of delivery vector does it use
Yescarta (axicabtagene ciloleucel) is a DNA-based CAR-T cell therapy delivered using a retroviral vector.
It is used to treat B-cell non-Hodgkin lymphoma and follicular lymphoma.
what is Vaxzevria, and how does it work
Vaxzevria (ChAdOx1) is a viral vector vaccine that uses an adenovirus to deliver DNA encoding the SARS-CoV-2 spike protein
It was developed to prevent COVID-19
what are BNT162b2 and mRNA-1273
They are mRNA vaccines developed by Pfizer-BioNTech and Moderna, respectively
Both use lipid nanoparticles (LNPs) to deliver mRNA and were developed to prevent COVID-19
what is Patisiran, and how is it delivered
Patisiran (Onpattro) is an siRNA-based RNA interference therapy delivered using lipid nanoparticles
It is used to treat transthyretin amyloidosis
what is Givosiran, and how is it delivered
Givosiran (Givlaari) is an siRNA-based RNA interference therapy delivered using a GalNAc conjugate
It is used to treat acute hepatic porphyria
what is Inclisiran, and what disease is it used to treat
Inclisiran (Leqvio) is a GalNAc-conjugated siRNA therapy used to treat familial hypercholesterolaemia
what is the difference between the delivery systems used for Patisiran, Givosiran and Inclisiran
Patisiran uses lipid nanoparticles.
Givosiran uses a GalNAc conjugate.
Inclisiran uses a GalNAc conjugate
which clinical nucleic acid therapies in the lecture use lipid nanoparticles
Patisiran, BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna)
which clinical therapies in the lecture use GalNAc delivery
Givosiran and Inclisiran
which clinical therapies in the lecture use viral vectors to deliver genetic material
Kymriah, Yescarta and Vaxzevria. The lecture also describes Gendicine and Luxturna as gene therapy products using viral vectors
summary table of the different nucleic acid therapies
